No Data
No Data
Goldman Sachs Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Raises Target Price to $27
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth
Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Express News | JP Morgan Maintains Overweight on Olema Pharmaceuticals, Lowers Price Target to $31
Express News | Olema Pharmaceuticals Inc : JP Morgan Cuts Target Price to $31 From $33
Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.